LRI Investments’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$528 Hold
39
﹤0.01% 1530
2026
Q1
$234 Hold
39
﹤0.01% 1395
2025
Q4
$280 Sell
39
-569
-94% -$4.5K ﹤0.01% 1334
2025
Q3
$6.49K Sell
608
-50
-8% -$491 ﹤0.01% 977
2025
Q2
$6.37K Hold
658
﹤0.01% 952
2025
Q1
$9.8K Sell
658
-6
-0.9% -$92 ﹤0.01% 798
2024
Q4
$9.91K Hold
664
﹤0.01% 792
2024
Q3
$10.2K Buy
664
+497
+298% +$10.3K ﹤0.01% 787
2024
Q2
$3.46K Hold
167
﹤0.01% 984
2024
Q1
$3.14K Buy
+167
New +$2.87K ﹤0.01% 693

Other funds holding OGN

LRI Investments's OGN Position: Q2 2026 in Review

LRI Investments held its Organon & Co (OGN) position steady in Q2 2026 at 39 shares worth $528. The position accounts for ﹤0.01% of the portfolio, ranked #1530.

LRI Investments first reported a position in OGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $10.2K in Q3 2024. 107 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • LRI Investments held 39 shares of Organon & Co worth $528 as of Q2 2026.
  • LRI Investments left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1530 holding.
  • LRI Investments first reported a position in Organon & Co in Q1 2024 and has held it in 10 quarters since.
  • LRI Investments's Organon & Co position peaked at $10.2K in Q3 2024.
  • 107 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.